JENNIFER GRIFFIN: Open Payments
NPI 1740621267 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,660 in 134 payments from 20 companies in 2025. Trend: 2023 $143 · 2024 $2,339 · 2025 $2,660
Food & beverage: $2,660
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $565 |
| Madrigal Pharmaceuticals | 11 | $318 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $286 |
| Ardelyx, Inc. | 9 | $220 |
| GENZYME CORPORATION | 10 | $171 |
| Verona Pharma, Inc. | 8 | $166 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $165 |
| QOL Medical, LLC | 6 | $148 |
| EVOKE PHARMA, INC. | 1 | $120 |
| Phathom Pharmaceuticals, Inc. | 9 | $110 |
Products named: REZDIFFRA, XIFAXAN, RINVOQ, DUPIXENT, IBSRELA, LINZESS, Ohtuvayre, ENTYVIO.
Industry payments across KY — which companies pay providers there.
